TVTX Sale Disclosure
Meckler Jeffrey A · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$111.17K
Meckler Jeffrey A Director
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 10, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 1 day later
TVTX daily price context
Close on/before transaction
$67.51
Sep 10, 2026
Close before public filing
$67.51
Sep 10, 2026
Return since public filing
-1.98%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,700 shares @ $65.39
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001506916-26-000004
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.79M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 10, 2026 | $174.4K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 10, 2026 | $265.2K |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 10, 2026 | $111.17K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 10, 2026 | $79.38K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 10, 2026 | $944.49K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 10, 2026 | $211.07K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 10, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 10, 2026 | $0 |